A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors

Clinical trial NCT02045095 · TERMINATED

Trial details

NCT number: NCT02045095
Sponsor: Millennium Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2014-01-31
Primary completion: 2016-11-09
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.